Publication:
Synthesis, molecular docking, and QSAR study of sulfonamide-based indoles as aromatase inhibitors

dc.contributor.authorPingaew R.
dc.contributor.authorMandi P.
dc.contributor.authorPrachayasittikul V.
dc.contributor.authorPrachayasittikul S.
dc.contributor.authorRuchirawat S.
dc.contributor.authorPrachayasittikul V.
dc.date.accessioned2021-04-05T03:21:50Z
dc.date.available2021-04-05T03:21:50Z
dc.date.issued2018
dc.date.issuedBE2561
dc.description.abstractThirty four of indoles bearing sulfonamides (11–44) were synthesized and evaluated for their anti-aromatase activities. Interestingly, all indole derivatives inhibited the aromatase with IC50 range of 0.7–15.3 μM. Indoles (27–36) exerted higher aromatase inhibitory activity than that of ketoconazole. The phenoxy analogs 28 and 34 with methoxy group were shown to be the most potent compounds with sub-micromolar IC50 values (i.e., 0.7 and 0.8 μM, respectively) without affecting to the normal cell line. Molecular docking demonstrated that the indoles 28, 30 and 34 could occupy the same binding site on the aromatase pocket and share several binding residues with those of the natural substrate (androstenedione), which suggested the competitive binding could be the mode of inhibition of the compounds. The most potent analog 28 could mimic H-bond interactions of the natural androstenedione with MET374 and ASP309 residues on the aromatase. QSAR model also revealed that the para-phenoxy indole (28) affords the higher value of electronegativity descriptor MATS6e as well as the higher inhibitory activity compared with that of the ortho-phenoxy compound (34). The study highlighted a series of promising indoles to be potentially developed as novel aromatase inhibitors for therapeutics. © 2017 Elsevier Masson SAS
dc.format.mimetypeapplication/pdf
dc.identifier.citationEuropean Journal of Medicinal Chemistry. Vol 143, (2018), p.1604-1615
dc.identifier.doi10.1016/j.ejmech.2017.10.057
dc.identifier.issn2235234
dc.identifier.other2-s2.0-85033552512
dc.identifier.urihttps://hdl.handle.net/20.500.14740/3907
dc.rights.holderScopus
dc.subject.other4 bromo n [2 (1h indol 3 yl)ethyl]benzenesulfonamide
dc.subject.other4 fluoro n [2 (1h indol 3 yl)ethyl]benzenesulfonamide
dc.subject.other4 trifluoromethyl n [2 (1h indol 3 yl)ethyl]benzenesulfonamide
dc.subject.otherAndrostenedione
dc.subject.otherAromatase
dc.subject.otherAromatase inhibitor
dc.subject.otherAspartic acid
dc.subject.otherEllipticine
dc.subject.otherIndole derivative
dc.subject.otherKetoconazole
dc.subject.otherLetrozole
dc.subject.otherMethionine
dc.subject.otherN,n' [(2,2' [(4 nitrophenyl)methylene]bis(1h indole 3,2 diyl)]bis(ethane 2,1 diyl)]bis(4 bromobenzenesulfonamide)
dc.subject.otherN,n' [(2,2' [(4 nitrophenyl)methylene]bis(1h indole 3,2 diyl)]bis(ethane 2,1 diyl)]bis(4 fluorobenzenesulfonamide)
dc.subject.otherN,n' [[2,2' [(4 bromophenyl)methylene]bis(1h indole 3,2 diyl)]bis(ethane 2,1 diyl)]bis(4 trifluoromethylbenzenesulfonamide)
dc.subject.otherN,n' [[2,2' [(4 cyanophenyl)methylene]bis(1h indole 3,2 diyl)]bis(ethane 2,1 diyl)]bis(4 chlorobenzenesulfonamide)
dc.subject.otherN,n' [[2,2' [(4 cyanophenyl)methylene]bis(1h indole 3,2 diyl)]bis(ethane 2,1 diyl)]bis(4 fluorobenzenesulfonamide)
dc.subject.otherN,n' [[2,2' [(4 cyanophenyl)methylene]bis(1h indole 3,2 diyl)]bis(ethane 2,1 diyl)]bis(4 trifluoromethylbenzenesulfonamide)
dc.subject.otherN,n' [[2,2' [(4 fluorophenyl)methylene]bis(1h indole 3,2 diyl)]bis(ethane 2,1 diyl)]bis(4 bromobenzenesulfonamide)
dc.subject.otherN,n' [[2,2' [(4 fluorophenyl)methylene]bis(1h indole 3,2 diyl)]bis(ethane 2,1 diyl)]bis(4 chlorobenzenesulfonamide)
dc.subject.otherN,n' [[2,2' [(4 fluorophenyl)methylene]bis(1h indole 3,2 diyl)]bis(ethane 2,1 diyl)]bis(4 trifluoromethylbenzenesulfonamide)
dc.subject.otherN,n' [[2,2' [(4 hydroxyphenyl)methylene]bis(1h indole 3,2 diyl)]bis(ethane 2,1 diyl)]bis(4 trifluoromethylbenzenesulfonamide)
dc.subject.otherN,n' [[2,2' [(4 nitrophenyl)methylene]bis(1h indole 3,2 diyl)]bis(ethane 2,1 diyl)]bis(4 trifluoromethylbenzenesulfonamide)
dc.subject.otherN,n' [[2,2' [(4 trifluoromethylphenyl)methylene]bis(1h indole 3,2 diyl)]bis(ethane 2,1 diyl)]bis(4 bromobenzenesulfonamide)
dc.subject.otherN,n' [[2,2' [(4 trifluoromethylphenyl)methylene]bis(1h indole 3,2 diyl)]bis(ethane 2,1 diyl)]bis(4 chlorobenzenesulfonamide)
dc.subject.otherN,n' [[2,2' [(4 trifluoromethylphenyl)methylene]bis(1h indole 3,2 diyl)]bis(ethane 2,1 diyl)]bis(4 trifluoromethylbenzenesulfonamide)
dc.subject.otherN,n' [[2,2' [(9 ethyl 9h carbazol 3 yl)methylene]bis(1h indole 3,2 diyl)]bis(ethane 2,1 diyl)]bis(4 chlorobenzenesulfonamide)
dc.subject.otherN,n' [[2,2' [(9h fluoren 2 yl)methylene]bis(1h indole 3,2 diyl)]bis(ethane 2,1 diyl)]bis(4 chlorobenzenesulfonamide)
dc.subject.otherSulfonamide
dc.subject.otherUnclassified drug
dc.subject.otherAromatase inhibitor
dc.subject.otherIndole derivative
dc.subject.otherSulfonamide
dc.subject.otherAnimal cell
dc.subject.otherArticle
dc.subject.otherBinding competition
dc.subject.otherControlled study
dc.subject.otherDrug binding site
dc.subject.otherDrug cytotoxicity
dc.subject.otherDrug mechanism
dc.subject.otherDrug potency
dc.subject.otherDrug protein binding
dc.subject.otherDrug screening
dc.subject.otherDrug synthesis
dc.subject.otherEnzyme active site
dc.subject.otherEnzyme inhibition
dc.subject.otherHydrogen bond
dc.subject.otherIC50
dc.subject.otherMolecular docking
dc.subject.otherNonhuman
dc.subject.otherQuantitative structure activity relation
dc.subject.otherAnimal
dc.subject.otherCell survival
dc.subject.otherChemical structure
dc.subject.otherChemistry
dc.subject.otherChlorocebus aethiops
dc.subject.otherDose response
dc.subject.otherDrug effects
dc.subject.otherMetabolism
dc.subject.otherMultivariate analysis
dc.subject.otherSynthesis
dc.subject.otherVero cell line
dc.subject.otherAnimals
dc.subject.otherAromatase
dc.subject.otherAromatase Inhibitors
dc.subject.otherCell Survival
dc.subject.otherCercopithecus aethiops
dc.subject.otherDose-Response Relationship, Drug
dc.subject.otherIndoles
dc.subject.otherMolecular Docking Simulation
dc.subject.otherMolecular Structure
dc.subject.otherMultivariate Analysis
dc.subject.otherQuantitative Structure-Activity Relationship
dc.subject.otherSulfonamides
dc.subject.otherVero Cells
dc.titleSynthesis, molecular docking, and QSAR study of sulfonamide-based indoles as aromatase inhibitors
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85033552512&doi=10.1016%2fj.ejmech.2017.10.057&partnerID=40&md5=eedc5b18d0eeabd0844d07d1c860d3f6

Files